Home โบ Depression
Depression clinical trials recruiting in the U.S.
421 studies for Depression are recruiting participants at sites across the United States.
Depression is a serious medical illness. It affects almost 7 percent of U.S. adults. It causes feelings of sadness, hopelessness, and frustration that do not go away. Learn about treatments.
Cities with the most studies
- Boston, MA51 studies
- New York City, NY46 studies
- Philadelphia, PA24 studies
- Chicago, IL23 studies
- Pittsburgh, PA22 studies
- Atlanta, GA22 studies
- San Diego, CA21 studies
- Charleston, SC19 studies
- Houston, TX18 studies
- Orlando, FL17 studies
- Los Angeles, CA17 studies
- Miami, FL16 studies
- Durham, NC15 studies
- Washington, DC15 studies
- San Francisco, CA15 studies
- St. Louis, MO15 studies
- Austin, TX15 studies
- Baltimore, MD14 studies
- Tampa, FL14 studies
- Aurora, CO13 studies
- Dallas, TX13 studies
- Columbus, OH11 studies
- Mountain View, CA10 studies
- Jacksonville, FL10 studies
- Seattle, WA10 studies
- Minneapolis, MN10 studies
- Little Rock, AR10 studies
- New Haven, CT9 studies
- Orange, CA9 studies
- Ann Arbor, MI9 studies
- Germantown, MD8 studies
- Birmingham, AL8 studies
- Cincinnati, OH8 studies
- Madison, WI8 studies
- Cambridge, MA7 studies
- Grand Prairie, TX7 studies
- Everett, WA7 studies
- The Bronx, NY7 studies
- Las Vegas, NV7 studies
- New Orleans, LA7 studies
By state
- Alabama14 studies
- Arizona12 studies
- Arkansas10 studies
- California69 studies
- Colorado20 studies
- Connecticut15 studies
- District of Columbia4 studies
- Florida45 studies
- Georgia26 studies
- Idaho3 studies
- Illinois27 studies
- Indiana6 studies
- Iowa5 studies
- Kansas6 studies
- Louisiana10 studies
- Maryland29 studies
- Massachusetts64 studies
- Michigan17 studies
- Minnesota15 studies
- Mississippi3 studies
- Missouri20 studies
- Montana3 studies
- Nebraska3 studies
- Nevada7 studies
- New Hampshire4 studies
- New Jersey12 studies
- New Mexico5 studies
- New York61 studies
- North Carolina26 studies
- Ohio26 studies
- Oklahoma12 studies
- Oregon8 studies
- Pennsylvania48 studies
- Rhode Island5 studies
- South Carolina20 studies
- Tennessee12 studies
- Texas51 studies
- Utah10 studies
- Virginia12 studies
- Washington20 studies
- Wisconsin11 studies
Recently updated studies
The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease
RecruitingPhase 2
Ages 40 to 80 ยท All sexes ยท Updated Sep 28, 2026 ยท NCT07610369Characterization and Treatment of Adolescent Depression
RecruitingObservational studyHealthy volunteers welcome
Ages 11 to 25 ยท All sexes ยท Updated Sep 28, 2026 ยท NCT03388606Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers
RecruitingObservational studyHealthy volunteers welcome
Ages 3 to 99 ยท All sexes ยท Updated Sep 28, 2026 ยท NCT00024635A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
RecruitingPhase 3
Ages 18 to 85 ยท All sexes ยท Updated Sep 25, 2026 ยท NCT06793397Heart Rate Variability (HRV)-Guided Transcranial Direct Current Stimulation (tDCS)
Recruiting
Ages 18 to 65 ยท All sexes ยท Updated Sep 25, 2026 ยท NCT06455527The WeACT Program for Family Caregivers of People Living With Dementia
Recruiting
Ages 18 and older ยท All sexes ยท Updated Sep 25, 2026 ยท NCT07342569A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Sep 25, 2026 ยท NCT07621237JAK Signaling in Depression and Cognition in Male Football Players
RecruitingPhase 2Healthy volunteers welcome
Ages 30 to 55 ยท Men ยท Updated Sep 24, 2026 ยท NCT07608796WellPATH-PREVENT: A Mobile Intervention for Middle-Aged and Older Adults Hospitalized for Suicidal Ideation or Attempt
Recruiting
Ages 50 to 90 ยท All sexes ยท Updated Sep 23, 2026 ยท NCT05183230Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 65 ยท All sexes ยท Updated Sep 22, 2026 ยท NCT03065335The Medically Tailored Groceries and Mental Health Study
Recruiting
Ages 18 and older ยท All sexes ยท Updated Sep 22, 2026 ยท NCT07779707Unified Protocol: Community Connections
Recruiting
Ages 7 to 17 ยท All sexes ยท Updated Sep 21, 2026 ยท NCT06038721Parent-Adolescent Relationships, Emotional Regulation, and HRV in Adolescents With Depression
RecruitingObservational study
Ages 12 to 18 ยท All sexes ยท Updated Sep 21, 2026 ยท NCT07430774Support for Bereaved Cancer Caregivers
RecruitingHealthy volunteers welcome
Ages 18 and older ยท All sexes ยท Updated Sep 18, 2026 ยท NCT06662409Confirmatory Efficacy of the Building a Strong Identity and Coping Skills Program
RecruitingHealthy volunteers welcome
Ages 11 and older ยท All sexes ยท Updated Sep 17, 2026 ยท NCT05789446A Remotely Delivered Tai Chi/Qigong Intervention for Older People Living With HIV
Recruiting
Ages 50 to 75 ยท All sexes ยท Updated Sep 16, 2026 ยท NCT06586619Brexanolone Lifting Outcomes Of Moms
RecruitingPhase 3
Ages 15 to 45 ยท Women ยท Updated Sep 16, 2026 ยท NCT07822321Lumateperone for Late-Life Depression
RecruitingPhase 3
Ages 60 and older ยท All sexes ยท Updated Sep 16, 2026 ยท NCT07623135Acoustic Stimulation, Sleep, and Cognitive-Emotional Processes in Young Adults With Anxiety and Depression Symptoms
Recruiting
Ages 18 to 25 ยท All sexes ยท Updated Sep 16, 2026 ยท NCT05802004Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression
RecruitingPhase 1Healthy volunteers welcome
Ages 21 to 45 ยท All sexes ยท Updated Sep 15, 2026 ยท NCT06480201Psilocybin as a Novel Therapy for Residual Anhedonia
RecruitingPhase 1
Ages 18 to 65 ยท All sexes ยท Updated Sep 15, 2026 ยท NCT07607938Transdiagnostic Cognitive Biomarkers
RecruitingHealthy volunteers welcome
Ages 18 and older ยท All sexes ยท Updated Sep 15, 2026 ยท NCT04864080Pattern Separation in Major Depressive Disorder
RecruitingPhase 1
Ages 18 to 50 ยท All sexes ยท Updated Sep 15, 2026 ยท NCT07139834RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
RecruitingPhase 2
Ages 18 to 80 ยท All sexes ยท Updated Sep 15, 2026 ยท NCT07002034A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
RecruitingPhase 2
Ages 18 to 65 ยท All sexes ยท Updated Sep 14, 2026 ยท NCT07065240From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.